ByMedullaxFebruary 7, 2026 MHRA Highlights Rare NAION Risk with Semaglutide (Wegovy, Ozempic, Rybelsus) Government & Funding Research & Evidence
ByMedullaxJanuary 30, 2026 Pancreatitis Risk: GLP-1 Agonist Warnings Strengthened Following Fatal Cases Government & Funding Research & Evidence
ByMedullaxJanuary 28, 2026 AI and optimisation enhance operating theatre efficiency for arthroplasty Research & Evidence
ByMedullaxJanuary 22, 2026 UK streamlines clinical trial approvals to boost research and patient access Government & Funding Research & Evidence
ByMedullaxJanuary 22, 2026 MHRA Strengthens Dependency and Addiction Warnings for Pain, Anxiety, Insomnia Medicines Government & Funding Research & Evidence
ByMedullaxJanuary 22, 2026 GPT-4o-Generated MCQs: Psychometric Properties and Detectability in Medical Imaging Clinical AI & Diagnostics Research & Evidence
ByMedullaxDecember 21, 2025 New £50m MRC Centre Aims to Transform Clinical Trials in the UK Research & Evidence
ByMedullaxDecember 21, 2025 Exploring the Potential of Sound Waves in Mitigating Brain Ageing Research & Evidence
ByMedullaxDecember 21, 2025 Midlife Depression Linked to Higher Dementia Risk: Key Findings Research & Evidence
ByMedullaxDecember 21, 2025 NERC Funding Insights on Predicting Christmas Weather Patterns Research & Evidence
